Inotiv Analyst Ratings
Lake Street Upgrades Inotiv(NOTV.US) to Buy Rating, Raises Target Price to $4
Analysts' Top Healthcare Picks: Inotiv (NOTV), Ironwood Pharma (IRWD)
Inotiv Upgraded to Buy From Hold at Lake Street
Lake Street Maintains Inotiv(NOTV.US) With Hold Rating, Maintains Target Price $2
Lake Street Maintains Inotiv(NOTV.US) With Hold Rating, Maintains Target Price $2
Lake Street Sticks to Their Hold Rating for Inotiv (NOTV)
Inotiv (NOTV) Gets a Hold From Lake Street
Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating
Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating
Inotiv (NOTV) Gets a Buy From Craig-Hallum
Inotiv (NOTV) Gets a Buy From Craig-Hallum
Inotiv Analyst Ratings
Inotiv Analyst Ratings
Jefferies Downgrades Inotiv to Hold From Buy, Price Target Is $3.75
Inotiv (NOTV) Receives a Buy From Craig-Hallum
Analysts Offer Insights on Healthcare Companies: Natera (NTRA) and Inotiv (NOTV)
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)
Craig-Hallum Keeps Their Buy Rating on Inotiv (NOTV)
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), BioLife Solutions (BLFS) and Inotiv (NOTV)
No Data
No Data